Clinical Trial Update: BARDA Securing Anthrax Immunity For the Elderly [Phase 2]

View source ↗

Summary

Phase 2 trial update on BARDA-supported anthrax immunity in the elderly has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Snippet

Sponsor: Biomedical Advanced Research and Development Authority | Conditions: Anthrax | Phase 2 | Status: COMPLETED | Results posted: 2020-06-09